• UCLA Health
  • myUCLAhealth
  • School of Medicine
CARE Center

AIDS Institute

CARE Center   |  

CARE Center
  • About Us
    • History
    • Awards & Accomplishments
    • Staff
    • Our Directors
    • Faculty
    • Donate
    • News & Events
  • Patient Care
    • Medical Care Coordination
  • Clinical Trials
    • Immune Modulators Studies
    • HIV Treatment Studies
    • Hepatitis Co-Infection Studies
    • Human Papillomavirus (HPV) Studies
    • Studies for Women
    • Lymphoma Studies
    • Kaposi's Sarcoma Studies
    • Non-AIDS Defining Cancer
    • HIV Prevention
    • Discussion Groups
    • FAQ
    • Testimonials
    • HIV Treatment Studies
    • Immune Modulators
    • Hepatitis Co-infection Studies
    • Anchor Study (HPV)
    • Studies for Women
    • Lymphoma Studies
    • Kaposi's Sarcoma Studies
    • Non-AIDS Defining Cancer
    • HIV Prevention
    • FAQ
    • Testimonials
  • Community
    • Community Advisory Board
    • Partner of the Month
    • Prevention CAB
  • Research
    • Network Support
    • Conferences
  • RSVP
  • Contact Us
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

AIDS Institute

CARE Center   |  

Research

Research

Research

  • Network Support
  • Conferences
  • Network Support
  • Conferences
  1. Home
  2. Research
  3. Conferences

Conferences

Share this

UCLA CARE Center faculty have presented research at international and national conferences:


19th Conference on Retroviruses and Opportunistic Infections (CROI)
March 5-8, 2012 | Seattle, WA

Judith Currier CROI 2012

Dr. Judith Currier kicked off the week with her presentation at the Program Committee Workshop for New Investigators and Trainees titled "Complications of HIV Disease and ART."
Watch the webcast of her presentation here ». (begins at 1:11:14)

UCLA CARE Center faculty and fellows were well-represented with a number of abstracts presented highlighting our cutting-edge research on gene therapy, cardiovascular disease, metabolic complications, hepatitis C co-infection, and inflammation.

Ultrasonographic Measures of CVD Risk in a Modern Cohort of ART-naïve HIV+ Individuals: Baseline Results from ACTG Study 5260s
James Stein, T Brown, H Ribaudo, Y Chen, M Yan, E Lauer-Brodell, G McComsey, M Dube, H Hodis, and J Currier

The Association between Body Composition, Soluble and Cellular Immune Activation Biomarkers, and BMD in ART-naïve HIV-1+ Persons: Baseline Results of ACTG Study A5260s Todd Brown, J Currier, Y Chen, H Ribaudo, J Touw, J Rothenberg, M Dube, R Murphy, J Stein, and G McComsey

Biomarkers of Microbial Translocation and Macrophage Activation Are Associated with Progression of Atherosclerosis in HIV Infection: ACTG NWCS 332/A5078 Study
Theodoros Kelesidis, O Yang, M Kendall, H Hodis, and J Currier

Progression of Atherosclerosis-Understanding RAGE: NWCS 332 Ann Danoff, M Kendall, J Currier, T Kelesidis, AM Schmidt, and J Aberg

Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for AIDS-related Lymphoma Anthony Cillo, A Krishnan, R Mitsuyasu, D McMahon, S Li, J Rossi, J Zaia, and J Mellors

Induction of Acquired CCR5 Deficiency with Zinc Finger Nuclease-modified Autologous CD4 T Cells (SB-728-T) Correlates with Increases in CD4 Count and Effects on Viral Load in HIV-infected Subjects
C June, Pablo Tebas, D Stein, R Mitsuyasu, J Lalezari, S Wang, G Lee5, B Levine, W Tang, and D Ando

A Single Infusion of Zinc Finger Nuclease CCR5 Modified Autologous CD4 T Cells (SB-728-T) Increases CD4 Counts and Leads to Decrease in HIV Proviral Load in an Aviremic HIV-infected Subject Jay Lalezari, R Mitsuyasu, S Wang, G Lee, M Giedlin, W Tang, K Spratt, R Surosky, N Dubois-Stringfellow, and D Ando

Impact of Chemotherapy for AIDS-related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive ART
Anthony Cillo, S Krishnan, D McMahon, R Mitsuyasu, M Para, and J Mellors

Pre-HAART Initiation Soluble CD14 Levels Vary by Country, Race, and Sex
Ashwin Balagopal, V Franco, L Smeaton, T Campbell, N Kumarasamy, J Hakim, R Mitsuyasu, R Bollinger, D Thomas, A Gupta, and ACTG PEARLS and NWCS 319 Study Team

Effects of Telmisartan on Markers of Monocyte Activation in HIV+ Patients on ART Jordan Lake J Currier, C-H Tseng, D Douek, and N Sandler

Associations between 25-Hydroxyvitamin D, Adipokines, and Measures of Insulin Glucose Homeostasis in HIV+ Patients
Jordan Lake, C-H Tseng, R Hoffman, and J Currier

Inflammatory and Coagulation Biomarker Trajectories from Late Pregnancy to 6 Weeks Postpartum in HIV+ Women Who Continue vs Discontinue ART after Delivery Risa Hoffman, E Leister, D Kacanek, D Shapiro, J Read, Y Bryson, and J Currier

Changes in Inflammatory Marker Concentrations during Randomized Feeding in Women Infected with HIV-1 Subtype C Elizabeth Russell, T Mohammed, B Jorowe, L Smeaton, R Hoffman, J Currier, S Moyo, M Essex, and S Lockman

Combination of Allele-specific Detection Techniques to Quantify Minority Resistance Variants in HBV, a Novel Approach Debika Bhattacharya, M Lewis, B Lassmann, T Phan, G Knecht, M Bickel, and O Yang

Measuring Fitness Cost of HCV Drug-resistance Mutations in a Fully Replication-competent Assay
B Lassmann, V Arumugaswami, K Chew, and Martha Lewis

Back to Top »

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Publications
  • Giving
  • Careers
  • Volunteer
  • Privacy Practices
  • Nondiscrimination
  • Emergency
  • Smoke-Free
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Report Broken Links
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth